Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |